Keyword Search Year None20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001 01/17/23 Alkermes Awarded Innovation Passport Designation by the MHRA (UK) for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
01/17/23 Alkermes Awarded Innovation Passport Designation by the MHRA (UK) for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
